The Cooper Companies (COO) reported a mix of ups and downs in their recent quarterly reports. Despite reporting
US$965M in Q1 sales growth, the stock fell by 15%. While Q1 earnings met estimates, the shares plummeted again due to a lack of confidence from investors and analysts. Several analysts from Stifel, Citi, and Needham & Company LLC have lowered their price targets for the COO stock. However, Cooper Companies maintains a "Moderate Buy" brokerage consensus rating. Despite challenges, Cooper Companies has shown
Q1 profit growth surpassing estimates and demonstrated formidable Q4 earnings. The company recently announced plans for acquisitions such as the
$875M purchase of Cook Medical’s reproductive health business. However, their debt usage and a new 52-week low on analyst downgrades have raised concerns. Overall, the future of the company remains uncertain as reflected in diversified fundamentals, and this varying performance has left investors and analysts speculating if the stock is a worthy addition to their portfolios.
The Cooper Companies COO News Analytics from Tue, 29 May 2018 07:00:00 GMT to Fri, 14 Mar 2025 17:37:32 GMT -
Rating -2
- Innovation 3
- Information 6
- Rumor -1
